Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-100
Closed -$18.5K 10334
2022
Q4
$18.5K Buy
+100
New +$17.6K ﹤0.01% 7735
2021
Q4
Sell
-200
Closed -$41K 10681
2021
Q3
$41K Buy
+200
New +$42.8K ﹤0.01% 6503
2021
Q1
Sell
-200
Closed -$38K 9440
2020
Q4
$38K Hold
200
﹤0.01% 6429
2020
Q3
$35K Hold
200
﹤0.01% 5891
2020
Q2
$31K Buy
+200
New +$30.5K ﹤0.01% 6250

Other funds holding STE

UBS Group's STE Position: Q1 2026 in Review

UBS Group increased its Steris (STE) stake by 6.7% in Q1 2026, buying an estimated $8.39M and bringing the position to 546,856 shares worth $121M. The position accounts for 0.02% of the portfolio, ranked #920.

UBS Group first reported a position in STE in Q4 2014 and has held it in 46 quarters since. The position peaked at $130M in Q4 2025. 840 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • UBS Group held 546,856 shares of Steris worth $121M as of Q1 2026.
  • UBS Group bought 34,283 Steris shares in Q1 2026, an estimated $8.39M.
  • Steris made up 0.02% of UBS Group's portfolio in Q1 2026, its #920 holding.
  • UBS Group first reported a position in Steris in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Steris position peaked at $130M in Q4 2025.
  • 840 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.